Sort
50,496 grants matching “lung cancer”
Novel Reagents and New Biomarkers for Lung Cancer
$577,457University Of Texas Sw Med Ctr/Dallas · U01 · FY2005 · CA
Restoring Salivary Gland Function by Reducing Nucleotide-induced Inflammation
$577,455Gary Andrew Weisman · University Of Missouri-Columbia · R01 · FY2015 · DE
The Duke Preclinical Research Resources for Quantitative Imaging Biomarkers
$577,389Cristian T Badea · Duke University · U24 · FY2021 · CA
Biomolecular Recognition and Binding Mechanisms
$577,321Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Etiologic Studies of Prostate Cancer
$577,301Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA
En Pareja: A Latino couples intervention to help expectant fathers quit smoking
$577,287Kathryn I Pollak · Duke University · R01 · FY2012 · CA
Computational analysis of tumor ecosystems and their regulation and association with outcomes
$577,261Andrew J. Gentles · Stanford University · R01 · FY2024 · CA
Dose-distribution radiomics to predict morbidity risk in radiotherapy
$577,261Joseph O Deasy · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
Quantitative PET Imaging of Hepatocellular Carcinoma (HCC)
$577,171Henry Charles Manning · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Image-guided TRAIL-enhanced CAR T-cell immunotherapy
$577,130Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
REDIRECTING VIRAL IMMUNITY TO ERADICATE LOW TUMOR MUTATION BURDEN LUNG CANCERS
$577,094The General Hospital Corporation · · FY2025 · Defense Health Agency
Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer
$577,069David P Carbone · Ohio State University · R01 · FY2021 · CA
Understanding Efficacy and Fe(II)-Promoted Activation of 1,2,4-Trioxolanes in Cancer
$577,035Eric Collisson · University Of California, San Francisco · R01 · FY2021 · CA
A Mechanoimmunological Basis for Metastatic Site Preference
$577,034Morgan A Huse · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Probing RAS-mediated Signaling with Monobody Inhibitors
$576,970John P O'Bryan · Medical University Of South Carolina · R01 · FY2023 · CA
Molecular and Genetic Analysis of Lung Cancer Survival
$576,794David C Christiani · Harvard School Of Public Health · R01 · FY2009 · CA
Senescent CAFs in Breast Cancer Progression
$576,723Sheila A Stewart · Washington University · R01 · FY2025 · AG
Targeting FAK-NEDD9 protein-protein interaction to prevent focal adhesion assembly and vascular proliferation in pulmonary arterial hypertension
$576,691Bradley Maron · University Of Maryland Baltimore · R01 · FY2025 · HL
Cancer Caregivers and Their Struggle(s) between Work and Family
$576,680Cathy J. Bradley · University Of Colorado Denver · R01 · FY2022 · CA
(PQ4) Novel tools for in vivo study of genetic interactions in cancer progression
$576,627Sidi Chen · Yale University · R01 · FY2021 · CA
(PQ4) Novel tools for in vivo study of genetic interactions in cancer progression
$576,627Sidi Chen · Yale University · R01 · FY2020 · CA
(PQ4) Novel tools for in vivo study of genetic interactions in cancer progression
$576,627Sidi Chen · Yale University · R01 · FY2018 · CA
Mobile Contingency Management for Smoking Cessation among Socioeconomically Disadvantaged Adults
$576,512Darla Elizabeth Kendzor · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2024 · CA
Stanford University NCTN- Network Lead Academic Site
$576,471Heather Ann Wakelee · Stanford University · U10 · FY2015 · CA
Stanford University NCTN- Network Lead Academic Site
$576,471Heather Ann Wakelee · Stanford University · U10 · FY2014 · CA